September 12, 2013JNCI Journal of the National Cancer Institute223 citations
Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer
View Full Paper
Key Points
Key points are not available for this paper at this time.
Abstract
None of the IHC4 markers provided statistically significant prognostic information in years 5 to 10, except for nodal status and tumor size. ROR gave the strongest prognostic information in years 5 to 10. These results may help select patients who could benefit most from hormonal therapy beyond 5 years of treatment.